Results 21 to 30 of about 15,495 (255)
Characterization of qnrB-carrying plasmids from ESBL- and non-ESBL-producing Escherichia coli
Abstract Background Escherichia coli carrying clinically important antimicrobial resistances [i.e., against extended-spectrum-beta-lactamases (ESBL)] are of high concern for human health and are increasingly detected worldwide.
Juraschek, Katharina +6 more
openaire +3 more sources
Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. [PDF]
\ud Antimicrobial resistance is fast becoming a global concern with rapid increases in multidrug-resistant Gram negative organisms. The prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates increases the burden on implementing
Kamugisha, Erasmus +19 more
core +1 more source
Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms [PDF]
The rapid and irrepressible increase in antimicrobial resistance of pathogenic bacteria that has been observed over the last two decades is widely accepted to be one of the major problems of human medicine today. Several aspects of this situation are especially worrying.
openaire +2 more sources
Extended spectrum b-lactamases (ESBLs) are enzymes encoded by mutation of a class of genes such as TEM, SHV, OXA and CTX etc. in gram negative Enterobacteriaceae.
Md. Hasanul Karim +2 more
doaj +1 more source
Background: Ceftolozane/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a high range of efficacy and broad-spectrum action against multidrug-resistant bacterial strains. Objectives: The present study aimed to analyze the in vitro activity
Marzieh Rahim Khorasani +3 more
doaj +1 more source
MDR, ESBLs and carbapenemase enzyme production patterns of Gram-negative isolates.
MDR, ESBLs and carbapenemase enzyme production patterns of Gram-negative isolates.
Dagimawie Tadesse (276579) +3 more
core +1 more source
Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases [PDF]
Background: ESBL- and carbapenemase-producing Pseudomonas aeruginosa are prevalent in, for example, the Middle East, Eastern Europe and Latin America, though rarer elsewhere. Because P. aeruginosa readily mutate to become carbapenem resistant via loss of
Vickers, Anna +4 more
core +1 more source
The aim of the present study was to characterize extended-spectrum β-lactamase (ESBLs) genes in multidrug resistant enterobacterial pathogens as well as commensal isolates from the Sudan during the period 2003 to 2007.
Malik I.A, Elhag K.M.
doaj +1 more source
Increasing reports of the pandemic nature of extended spectrum β-lactamase (ESBL) producing bacteria in clinical infections called for more surveillance to identify possible sources of infection.
S.A. Balogun +3 more
doaj +1 more source
Initial Screening Tests for ESBLs.
For K. oxytoca, the breakpoints of the CPD, CRO, and ATM zones are ≤17 mm, ≤25 mm, and ≤27 mm, respectively. According to the CLSI, “Zones above may indicate ESBL production.”Abbreviations: ESBL, extended-spectrum β-lactamase; CPD, cefpodoxime; ATM ...
Yoshichika Arakawa (183806) +9 more
core +1 more source

